The predicted impact of vaccination on h
β
Megan A. Smith; Karen Canfell; Julia M.L. Brotherton; Jie-Bin Lew; Ruanne V. Bar
π
Article
π
2008
π
John Wiley and Sons
π
French
β 395 KB
## Abstract Vaccines based on human papillomavirus (HPV) 16 and 18 virusβlike particles have the potential to prevent βΌ70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and includes routine vaccination of females aged 12β13 years, and a 2βyear school and